erasmus urology research
News & updates
Erasmus MC actively including patients in Dutch Bladder Cancer Biorepository
Erasmus MC is the most actively engaged center in a Dutch Bladder Cancer Biorepository (https://www.probci.nl/), contributing significantly to advancing scientific research in bladder cancer.
New publication: Research protocol to identify progression and death amongst patients with metastatic hormone-sensitive prostate cancer treated with available treatments: PIONEER IMI’s “big data for better outcomes” program
Abstract Juan Gomez Rivas 1, Rossella Nicoletti 2, Laura Ibáñez 1, Carl Steinbeisser 3, Bertrand de Meulder 4, Asieh Golozar 5, Susan Evans Axelsson 6, Robert Snijder 7, Anders Bjartell 6, Philip Cornford 8, Mieke Van Hemelrijck 9, Katharina Beyer 9, Peter-Paul...
New publication: Regional variation in urinary catheter use in the Netherlands from 2012 to 2021: a population-based cohort
Abstract Felice E E van Veen 1, Jeroen R Scheepe 2, Bertil F M Blok 2 Objectives: Our aim was to evaluate trends and regional differences in the use of indwelling and intermittent urinary catheters in the community setting in the Netherlands from 2012 to 2021....
New publication: Darolutamide added to docetaxel augments antitumor effect in models of prostate cancer through cell cycle arrest at the G1-S transition
Abstract Stefan A J Buck 1, Annelies Van Hemelryk 2, Corrina de Ridder 2, Debra Stuurman 2, Sigrun Erkens-Schulze 2, Sem Van 't Geloof 2, Wilma J Teubel 3, Stijn L W Koolen 2, Elena S Martens-Uzunova 4, Martin E van Royen 2, Ronald de Wit 1, Ron H J...
New publication: Early Detection of Prostate Cancer in the European Union: Combining Forces with PRAISE-U
Abstract Hendrik Van Poppel 1, Monique J Roobol 2, Arunah Chandran 3 The European Association of Urology, together with consortium partners, has launched PRAISE-U (Prostate Cancer Awareness and Initiative for Screening in the European Union), a project involving 25...
CHASIT Studie uitgelicht bij UroToday in de rubriek ‘Beyond the Abstract’
Sequential Chemo-Immunotherapy in Patients with Locally Advanced Urothelial Cancer – a Non-Randomized Phase II Clinical Trial - Beyond the Abstract The CHASIT study was highlighted by UroToday in the section 'Beyond the Abstract'. In this section, authors can provide...
Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office
Abstract Joost L Boormans 1, Richard Sylvester 2, Lynn Anson-Cartwright 3, Rachel M Glicksman 4, Robert J Hamilton 3, Ezra Hahn 5, Gedske Daugaard 6, Jakob Lauritsen 6, Thomas Wagner 6, Barbara Avuzzi 7, Nicola Nicolai 8, Xavier García Del Muro 9, Jorge...
Prostate Cancer Mortality Among Elderly Men After Discontinuing Organised Screening: Long-term Results from the European Randomized Study of Screening for Prostate Cancer Rotterdam
Abstract Ivo I. de Vos, Sebastiaan Remmers, Renée Hogenhout, Monique J. Roobol, ERSPC Rotterdam Study Group Background: The optimal timing for discontinuing screening of prostate cancer (PCa) in elderly men is currently not known and remains debated. Objective: To...
New publication: Relationship Between Baseline Prostate-specific Antigen on Cancer Detection and Prostate Cancer Death: Long-term Follow-up from the European Randomized Study of Screening for Prostate Cancer
Abstract Sebastiaan Remmers 1, Chris H Bangma 2, Rebecka A Godtman 3, Sigrid V Carlsson 4, Anssi Auvinen 5, Teuvo L J Tammela 6, Louis J Denis 7, Vera Nelen 8, Arnauld Villers 9, Xavier Rebillard 10, Maciej Kwiatkowski 11, Franz Recker 12, Stephen Wyler 13, Marco...